Errington, Fiona <br/><br/>
Differences in the longevity of topo IIalpha and topo IIbeta drug-stabilized cleavable complexes and the relationship to drug sensitivity.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  Feb 2004 
 - 155-62 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0344-5704 
<br/><br/><label>Standard No.: </label>10.1007/s00280-003-0701-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amsacrine--pharmacology<br/>Animals<br/>Antigens, Neoplasm<br/>Antineoplastic Agents--pharmacology<br/>Antineoplastic Agents, Phytogenic--pharmacology<br/>DNA Topoisomerases, Type II--chemistry<br/>DNA, Neoplasm--chemistry<br/>DNA-Binding Proteins<br/>Etoposide--pharmacology<br/>Fibroblasts--enzymology<br/>Fluorescein-5-isothiocyanate<br/>Fluorescent Antibody Technique<br/>Fluorescent Dyes<br/>Half-Life<br/>Isoenzymes--chemistry<br/>Kinetics<br/>Mice<br/>Mitoxantrone--pharmacology